Skip to main content
. 2019 May 13;14:995–1008. doi: 10.2147/COPD.S195382

Table 3.

Direct health care costs and utilization in patients with early versus late COPD diagnosis

Variablea Early diagnosis
(N=3,870)
Late diagnosis
(N=8,827)
p-value
Cost per patient, Euro (95% CI)
 Total for respiratory drugs (R03) 386.5 (353.7–419.4) 900.1 (878.3–921.8) <0.0001
 Public cost 314.0 (283.9–344.1) 782.1 (762.1–802) <0.0001
 Individual patient cost 72.6 (68.4–76.8) 118.0 (115.3–120.8) <0.0001
 Total drug cost per patient 460.8 (396.6–524.9) 716.6 (674.2–759.1) <0.0001
 Public cost 373.2 (310.4–436.0) 595.3 (553.7–636.8) <0.0001
 Individual patient cost 87.6 (80.0–95.3) 121.4 (116.4–126.5) <0.0001
Utilization per patient per year, n (95% CI)
 Nights at hospital (COPD-related; J45) 0.16 (0.03–0.38) 1.17 (1.02–1.30) <0.0001
 Nights at hospital (non-COPD) 11.65 (11.04–12.55) 11.58 (11.01–12.02) 0.5487
 Hospitalization events (COPD-related; J44) 0.03 (0.01–0.05) 0.17 (0.16–0.18) <0.0001
 Hospitalization events (non-COPD) 1.68 (1.59–1.78) 1.79 (1.72–1.85) 0.0933
 Out hospital visitsb (COPD-related; J45) 0.04 (0.02–0.06) 0.15 (0.14–0.16) <0.0001
 Out hospital visitsb (non-COPD) 3.76 (3.44–4.02) 4.74 (4.56–4.94) <0.0001
 Primary care contact with physician 13.06 (12.41–13.73) 15.77 (15.33–16.21) <0.0001
 Primary care contact with persons other than physician 9.20 (8.42–9.98) 12.48 (11.96–13.00) <0.0001
 Number of referrals 0.99 (0.91–1.06) 1.22 (1.17–1.28) <0.0001

Notes: aAll variables are calculated with age as a covariate. Data are for the 2 years following COPD diagnosis. bOut hospital visit: a visit where the patient does not stay overnight at the hospital. R03 indicates the ATC prescription code for respiratory disease. Exchange rates in 2013, 8 Swedish Krona= 1 Euro.